Results 211 to 220 of about 5,584,318 (357)
Chemosynthesis enhances net primary production and nutrient cycling in a hypersaline microbial mat [PDF]
Francesco Ricci +11 more
openalex +1 more source
Relacions de la medicina catalana amb les diferents escoles mèdiques d'Europa i Amèrica durant el període 1890-1939 [PDF]
Net, Àlvar
core
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Dataset from the life cycle assessment and techno-economic analysis of net and longline nearshore <i>Saccharina latissima</i> cultivation systems. [PDF]
Sainz de la Maza Larrea A +5 more
europepmc +1 more source
THE LAYERED NET SURFACE PROBLEMS IN DISCRETE GEOMETRY AND MEDICAL IMAGE SEGMENTATION
Xiaodong Wu +3 more
openalex +2 more sources
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen +9 more
wiley +1 more source
Attention and residual mechanism-based CNN architecture (ARC-Net) with enhanced fairness generalization for deepfake facial image detection. [PDF]
Reza MS, Elias F, Mahmud MI, Ahmed N.
europepmc +1 more source
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source

